Evonik Industries AG (FRA:EVKA) Cyclically Adjusted Revenue per Share: €16.75 (As of Mar. 2026)


FRA:EVKA Evonik Industries AG FRA:EVKA
70 GF Score
Price €7.80
GF Value €7.73
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Evonik Industries AG Cyclically Adjusted Revenue per Share?

Evonik Industries AG FRA:EVKA 70 Cyclically Adjusted Revenue per Share is €16.75 as of Mar. 2026. GuruFocus rates FRA:EVKA with a GF Score™ of 70/100 and a GF Value™ of €7.73 (Fairly Valued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Evonik Industries AG's adjusted revenue per share for the three months ended in Mar. 2026 was €3.701. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €16.75 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Evonik Industries AG's average Cyclically Adjusted Revenue Growth Rate was 0.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Evonik Industries AG was 5.50% per year. The lowest was 0.60% per year. And the median was 3.50% per year.

As of today (2026-07-12), Evonik Industries AG's current stock price is €7.80. Evonik Industries AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €16.75. Evonik Industries AG's Cyclically Adjusted PS Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Evonik Industries AG was 1.01. The lowest was 0.36. And the median was 0.60.


Evonik Industries AG  (FRA:EVKA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Evonik Industries AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.80/16.75
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Evonik Industries AG was 1.01. The lowest was 0.36. And the median was 0.60.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Evonik Industries AG Cyclically Adjusted Revenue per Share Related Terms


Evonik Industries AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Evonik Industries AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evonik Industries AG Cyclically Adjusted Revenue per Share Chart

Evonik Industries AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.31 16.26 16.77 17.04 16.65

Evonik Industries AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.02 17.94 16.81 16.65 16.75

FRA:EVKA vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Evonik Industries AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evonik Industries AG Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Evonik Industries AG's Cyclically Adjusted PS Ratio falls into.


FRA:EVKA
70GF Score
Evonik Industries AG FRA:EVKA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evonik Industries AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evonik Industries AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.701/131.2583*131.2583
=3.701

Current CPI (Mar. 2026) = 131.2583.

Evonik Industries AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.455 100.717 4.503
201609 3.405 101.017 4.424
201612 3.421 101.217 4.436
201703 3.901 101.417 5.049
201706 3.899 102.117 5.012
201709 3.838 102.717 4.904
201712 3.837 102.617 4.908
201803 3.459 102.917 4.412
201806 3.645 104.017 4.600
201809 3.612 104.718 4.527
201812 3.505 104.217 4.414
201903 3.507 104.217 4.417
201906 3.553 105.718 4.411
201909 3.464 106.018 4.289
201912 3.533 105.818 4.382
202003 3.492 105.718 4.336
202006 2.976 106.618 3.664
202009 3.132 105.818 3.885
202012 3.489 105.518 4.340
202103 3.611 107.518 4.408
202106 3.920 108.486 4.743
202109 4.118 109.435 4.939
202112 4.421 110.384 5.257
202203 4.799 113.968 5.527
202206 5.142 115.760 5.830
202209 5.243 118.818 5.792
202212 4.643 119.345 5.106
202303 4.261 122.402 4.569
202306 4.174 123.140 4.449
202309 4.125 124.195 4.360
202312 3.947 123.773 4.186
202403 4.015 125.038 4.215
202406 3.930 125.882 4.098
202409 4.124 126.198 4.289
202412 3.899 127.041 4.028
202503 4.053 127.779 4.163
202506 3.791 128.412 3.875
202509 3.679 129.255 3.736
202512 3.652 129.361 3.706
202603 3.701 131.258 3.701

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €16.75 mean?
Evonik Industries AG (FRA:EVKA) has a Cyclically Adjusted Revenue per Share of €16.75 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Evonik Industries AG and its competitors.
Is Evonik Industries AG's Cyclically Adjusted Revenue per Share too high?
Evonik Industries AG's current Cyclically Adjusted Revenue per Share is €16.75. Overall, Evonik Industries AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Cyclically Adjusted Revenue per Share compare to LIN and SHW?
Evonik Industries AG's Cyclically Adjusted Revenue per Share of €16.75 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Evonik Industries AG and its competitors. Evonik Industries AG's current Cyclically Adjusted Revenue per Share is €16.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (FRA:EVKA) is currently considered Fairly Valued. The stock's GF Value™ is €7.73, compared to a current price of €7.80 — trading 0.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €16.75. Evonik Industries AG's overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Evonik Industries AG (FRA:EVKA), the current Cyclically Adjusted Revenue per Share is €16.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evonik Industries AG (FRA:EVKA) Overvalued in 2026?

Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued. The current stock price of €7.80 is trading 0.9% above its estimated GF Value™ of €7.73. GuruFocus considers Evonik Industries AG to be Fairly Valued.

Key valuation signals for FRA:EVKA:

  • Cyclically Adjusted Revenue per Share: €16.75
  • GF Value™: €7.73 vs. price of €7.80 (0.9% above fair value)
  • GF Score™: 70/100 with 9 warning signs

No single metric tells the full story. See the FRA:EVKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evonik Industries AG Business Description

Address Rellinghauser Strasse 1-11, Essen, NW, DEU, 45128
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
70GF Score

Get the complete analysis for FRA:EVKA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.80
Price
€7.73
GF Value